Endocrine toxicity in cancer patients treated with nivolumab or pembrolizumab: results of a large multicentre study - Presotto, E M; Rastrelli, G; Desideri, I (J Endocrinol Invest, 2020)
. doi:10.1007/s40618-019-01112-8